- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
LONDON, 14 October 2025 – Declining survey response rates, chronic underfunding, growing politicization of government agencies, and delayed reporting due to the government shutdown have all combined to undermine market confidence in official government data at precisely the time accurate labor market insights are most critical for assessing the true state of the economy in […]
Kirkland & Ellis top M&A legal adviser during Q1-Q3 2025, finds GlobalData
Kirkland & Ellis has emerged as the top mergers and acquisitions (M&A) legal adviser during Q1-Q3 2025 in terms of both value and volume in the latest Legal Advisers League Table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database reveals that Kirkland & Ellis achieved the leading position […]
Goldman Sachs and Houlihan Lokey top M&A financial advisers by value and volume during Q1-Q3 2025, finds GlobalData
Goldman Sachs and Houlihan Lokey have emerged as the top mergers and acquisitions (M&A) financial advisers by value and volume during Q1-Q3 2025 in the latest Financial Advisers League Table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Financial Deals Database reveals that Goldman Sachs achieved the leading position in terms […]
Surge in out-licensing deals drive China’s international pharma collaborations, says GlobalData
China’s out-licensing deals have significantly increased over the last five years, showcasing the country as a source of innovative drugs. The licensing agreements provide global recognition as well as validation for China’s advancements in drug development. With China-origin innovations becoming must-watch opportunities for global pharma, collaborations with the US and EU are reaching record scale […]
APAC EV charging infrastructure market to record 13.8% CAGR over 2025-30, forecasts GlobalData
The availability, reliability, and speed of charging are now the linchpins of consumer confidence in electric vehicles (EVs) in the Asia-Pacific (APAC) region. Beyond battery breakthroughs, the build-out of a robust, conveniently located charging network—and continued reductions in charging time—can be the decisive catalyst that converts range anxiety into real-world adoption of EVs in a […]
Global 6500 aircraft with advanced radars to equip South Korea to close critical intelligence gaps, says GlobalData
South Korea recently selected L3Harris Technologies to supply four Bombardier Global 6500 aircraft in a strategic move to enhance its aerial surveillance and intelligence-gathering capabilities. The aircraft will be equipped with ELTA Systems’ advanced dual-band EL/W-2085 conformal radar. The acquisition is expected to enable South Korea to strengthen its air defence network, maintain operational readiness […]
Medtronic US IDE study for Hugo system underscores growing role of robotics in women’s health, says GlobalData
Medtronic has initiated the Embrace Gynecology US investigational device exemption (IDE) study to evaluate the safety and effectiveness of its Hugo robotic-assisted surgery (RAS) system in gynecological procedures. The move reflects the increasing importance of robotics and integrated surgical platforms in women’s health and underscores the drive toward more precise, efficient, and patient-centric minimally invasive […]
Top APAC companies add $982 billion in MCap in Q3 2025, driven by AI and semiconductor boom, reveals GlobalData
Asia-Pacific (APAC) corporate heavyweights posted a mixed but broadly resilient performance in Q3 2025, with technology companies powering most of the gains. The region’s top 50 companies added $982.7 billion in market value between Q2 and Q3 2025, driven largely by semiconductor and AI optimism, while energy and consumer sectors lagged amid softening demand and […]
Cisco differentiates with bold AI strategy at WebexOne 2025, says GlobalData
Cisco wrapped up the 2025 edition of its annual marquee event “WebexOne,” showcasing AI-powered enhancements to the Webex platform across collaboration, contact center, and devices. This year greater emphasis was placed on Cisco’s AI strategy with the enhancements cast as enablers of the strategy encompassing three pillars: “Intentional AI,” “Connected Intelligence,” and “Open Ecosystems,” according […]
Top 25 global banks see over 34% increase in MCap in Q3 2025, reveals GlobalData
JPMorgan Chase retains top spot European banks continued to post strong gains The aggregate market capitalization (MCap) of the top 25 global banks increased by 34.3% year-on-year (YoY) to reach $5.6 trillion in the third quarter (Q3) ended 30 September 2025, as region-specific macroeconomic dynamics, central banks’ interest rate cuts, and strong capital market activity […]
China continues to make strides in innovative drug development, says GlobalData
Formerly regarded as a “me-too” producer, China has continued to expand its innovation capabilities within the last 10 years, whilst gaining traction as a major competitor within the international pharmaceutical landscape, according to GlobalData, a leading data and analytics company. Over the last decade, the Chinese government has incorporated numerous regulatory initiatives, such as China’s […]
GSK’s Phase III depemokimab data to support FDA approval in asthma and chronic rhinosinusitis, says GlobalData
GSK’s clinical data for depemokimab positions the asset for potential FDA approval in asthma and chronic rhinosinusitis, according to reporting by the Insights Investigative News team at GlobalData, a leading data and analytics company. Depemokimab acts by targeting interleukin-5 (IL-5) to reduce eosinophil-driven inflammation and is administered as a twice-yearly subcutaneous injection. The asset has […]
New GMP standards in India expose fault line between regulators and MSMEs, says GlobalData
India’s small drugmakers are sounding the alarm as new good manufacturing practice (GMP) and bio-equivalence mandates could deepen the divide between regulators and micro, small and medium enterprises (MSME). Their appeal to delay enforcement highlights growing concern that India’s drive for stricter quality standards, while well-intentioned, may strain smaller manufacturers, forcing consolidation, factory shutdowns, and […]
Tech in 2035: Join GlobalData’s webinar to explore the technologies that will transform people’s lives over the next decade
Profound shifts in the global economy are underway, driven by various factors, including demographic changes, climate change, supply chain disruptions, and geopolitical tensions. Technology adoption and innovation will accelerate over the next decade as enterprises, governments, and individuals adapt to these new realities. As a result, the world will look very different by 2035, says […]
Atrial fibrillation market to decline to $10.5 billion across 8MM in 2032, forecasts GlobalData
The atrial fibrillation (AF) market across the eight major markets (8MM*) is forecast to decline at a negative compound annual growth rate (CAGR) of 3.2% from $14.5 billion in 2022 to $10.5 billion in 2032, primarily driven by generic sales erosion of the leading novel oral anticoagulants ((NOACs), forecasts GlobalData, a leading data and analytics […]
uniQure’s gene therapy for Huntington’s disease holds blockbuster potential, says GlobalData
uniQure recently announced that its novel gene therapy, AMT-130 (ifezuntirgene inilparvovec), demonstrated statistically significant disease slowing in a Huntington’s disease (HD) pivotal trial. The results indicate that AMT-130 holds blockbuster potential in the disease space, according to GlobalData, leading data and analytics company. Pippa Salter, Managing Neurology Analyst at GlobalData, comments: “In a market where […]
High tech security measures may keep shoplifters out but also keep shoppers away, says GlobalData
UK retailers are alienating their own customers with inconvenient and intrusive security measures. Given the impulse nature of convenience shopping, the implementation of these newer surveillance and restrictive merchandising strategies could be as damaging to profits as the theft itself, according to the latest insights from GlobalData, a leading data and analytics company. Note: The […]
Global mRNA vaccine venture financing declines 82% in 2025YTD, reveals GlobalData
Venture financing for mRNA-based innovator vaccines saw an 82% decline from $510 million in 2023 to $90 million in 2025 year-to-date (YTD). In addition, the US Department of Health and Human Services’ (HHS) $500 million cut in grant support for mRNA vaccine projects announced in August 2025 has created uncertainty for biotech developers and may […]
Diagnosed prevalent cases of idiopathic pulmonary fibrosis to increase by 1.58% AGR in 7MM during 2024-34, forecasts GlobalData
The diagnosed prevalent cases of idiopathic pulmonary fibrosis (IPF) in the seven major markets (*7MM) are projected to increase from 199,146 in 2024 to 230,591 in 2034 at an annual growth rate (AGR) of 1.58%, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Idiopathic Pulmonary Fibrosis (IPF) – Epidemiology Forecast to 2034,” […]
Telecom service revenue in Vietnam to increase at 2.6% CAGR between 2024 and 2029, forecasts GlobalData
The total telecom services revenue in Vietnam is expected to increase at a compound annual growth rate (CAGR) of 2.6% during 2024-2029, led by growth in mobile data and fixed broadband segments, reveals GlobalData, a leading data and analytics company. GlobalData’s Vietnam Telecom Operators Country Intelligence Report reveals that the mobile voice service revenue will […]
